APO Research
Talk to an analyst

APO RESEARCH · REPORT

Actinic Keratosis Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Actinic Keratosis Drugs Industry Growth and Trends Forecast to 2032

20 December 2025102 pages

Choose your research edition.

Industry ResearchActinic Keratosis Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Actinic Keratosis Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Actinic Keratosis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Actinic Keratosis Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Actinic Keratosis Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Actinic Keratosis Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Actinic Keratosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Actinic Keratosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Actinic Keratosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Actinic Keratosis Drugs include Novartis, Vidac Pharma, Valeant, TOLMAR Pharmaceuticals, Taro Pharmaceutical Industries, Promius Pharma, Perrigo, LEO Pharma and GALDERMA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Actinic Keratosis Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Actinic Keratosis Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Actinic Keratosis Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Actinic Keratosis Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Actinic Keratosis Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Actinic Keratosis Drugs Market by Company

Novartis

Vidac Pharma

Valeant

TOLMAR Pharmaceuticals

Taro Pharmaceutical Industries

Promius Pharma

Perrigo

LEO Pharma

GALDERMA

Biofrontera

Almirall

Actinic Keratosis Drugs Segment by Type

Photodynamic Therapy Drugs

Topical Treatment Drugs

Combination Therapy Drugs

Actinic Keratosis Drugs Segment by Application

Hospitals

Clinics

Others

Actinic Keratosis Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Actinic Keratosis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Actinic Keratosis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Actinic Keratosis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Actinic Keratosis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Actinic Keratosis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Photodynamic Therapy Drugs Table 2. Major Company of Topical Treatment Drugs Table 3. Major Company of Combination Therapy Drugs Table 4. Global Actinic Keratosis Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Actinic Keratosis Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Actinic Keratosis Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Actinic Keratosis Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Actinic Keratosis Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Actinic Keratosis Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Actinic Keratosis Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Actinic Keratosis Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Actinic Keratosis Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Actinic Keratosis Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Actinic Keratosis Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Actinic Keratosis Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Actinic Keratosis Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Actinic Keratosis Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Actinic Keratosis Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Actinic Keratosis Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Actinic Keratosis Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Actinic Keratosis Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Actinic Keratosis Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Actinic Keratosis Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Actinic Keratosis Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Actinic Keratosis Drugs Industry Trends Table 26. Actinic Keratosis Drugs Industry Drivers Table 27. Actinic Keratosis Drugs Industry Opportunities and Challenges Table 28. Actinic Keratosis Drugs Industry Restraints Table 29. Global Actinic Keratosis Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Actinic Keratosis Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Actinic Keratosis Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Actinic Keratosis Drugs Sales Share by Company (2021-2026) Table 33. Global Actinic Keratosis Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Actinic Keratosis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Actinic Keratosis Drugs Major Company Production Sites and Headquarters Table 36. Global Actinic Keratosis Drugs Company, Product Type & Application Table 37. Global Actinic Keratosis Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Actinic Keratosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Actinic Keratosis Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Actinic Keratosis Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Actinic Keratosis Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Actinic Keratosis Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Actinic Keratosis Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Actinic Keratosis Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Actinic Keratosis Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Actinic Keratosis Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Actinic Keratosis Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Actinic Keratosis Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Actinic Keratosis Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Actinic Keratosis Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Actinic Keratosis Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Actinic Keratosis Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Actinic Keratosis Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Actinic Keratosis Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Actinic Keratosis Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Actinic Keratosis Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Actinic Keratosis Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Actinic Keratosis Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Actinic Keratosis Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Actinic Keratosis Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Actinic Keratosis Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Actinic Keratosis Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Actinic Keratosis Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Actinic Keratosis Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Actinic Keratosis Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Actinic Keratosis Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Actinic Keratosis Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Actinic Keratosis Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Actinic Keratosis Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Actinic Keratosis Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Actinic Keratosis Drugs Product Portfolio Table 76. Novartis Recent Development Table 77. Vidac Pharma Company Information Table 78. Vidac Pharma Business Overview Table 79. Vidac Pharma Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Vidac Pharma Actinic Keratosis Drugs Product Portfolio Table 81. Vidac Pharma Recent Development Table 82. Valeant Company Information Table 83. Valeant Business Overview Table 84. Valeant Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Valeant Actinic Keratosis Drugs Product Portfolio Table 86. Valeant Recent Development Table 87. TOLMAR Pharmaceuticals Company Information Table 88. TOLMAR Pharmaceuticals Business Overview Table 89. TOLMAR Pharmaceuticals Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. TOLMAR Pharmaceuticals Actinic Keratosis Drugs Product Portfolio Table 91. TOLMAR Pharmaceuticals Recent Development Table 92. Taro Pharmaceutical Industries Company Information Table 93. Taro Pharmaceutical Industries Business Overview Table 94. Taro Pharmaceutical Industries Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Taro Pharmaceutical Industries Actinic Keratosis Drugs Product Portfolio Table 96. Taro Pharmaceutical Industries Recent Development Table 97. Promius Pharma Company Information Table 98. Promius Pharma Business Overview Table 99. Promius Pharma Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Promius Pharma Actinic Keratosis Drugs Product Portfolio Table 101. Promius Pharma Recent Development Table 102. Perrigo Company Information Table 103. Perrigo Business Overview Table 104. Perrigo Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Perrigo Actinic Keratosis Drugs Product Portfolio Table 106. Perrigo Recent Development Table 107. LEO Pharma Company Information Table 108. LEO Pharma Business Overview Table 109. LEO Pharma Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. LEO Pharma Actinic Keratosis Drugs Product Portfolio Table 111. LEO Pharma Recent Development Table 112. GALDERMA Company Information Table 113. GALDERMA Business Overview Table 114. GALDERMA Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GALDERMA Actinic Keratosis Drugs Product Portfolio Table 116. GALDERMA Recent Development Table 117. Biofrontera Company Information Table 118. Biofrontera Business Overview Table 119. Biofrontera Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Biofrontera Actinic Keratosis Drugs Product Portfolio Table 121. Biofrontera Recent Development Table 122. Almirall Company Information Table 123. Almirall Business Overview Table 124. Almirall Actinic Keratosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Almirall Actinic Keratosis Drugs Product Portfolio Table 126. Almirall Recent Development Table 127. North America Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Actinic Keratosis Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Actinic Keratosis Drugs Sales Market Share by Country (2021-2026) Table 130. North America Actinic Keratosis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Actinic Keratosis Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. North America Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Actinic Keratosis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Actinic Keratosis Drugs Market Share by Country (2021-2026) Table 135. North America Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Actinic Keratosis Drugs Market Share Forecast by Country (2027-2032) Table 137. Europe Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Actinic Keratosis Drugs Sales by Country (2021-2026) & (K Units) Table 139. Europe Actinic Keratosis Drugs Sales Market Share by Country (2021-2026) Table 140. Europe Actinic Keratosis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Actinic Keratosis Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Actinic Keratosis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Actinic Keratosis Drugs Market Share by Country (2021-2026) Table 145. Europe Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Actinic Keratosis Drugs Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Actinic Keratosis Drugs Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Actinic Keratosis Drugs Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Actinic Keratosis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Actinic Keratosis Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Actinic Keratosis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Actinic Keratosis Drugs Market Share by Country (2021-2026) Table 155. Asia-Pacific Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Actinic Keratosis Drugs Market Share Forecast by Country (2027-2032) Table 157. Latin America Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Actinic Keratosis Drugs Sales by Country (2021-2026) & (K Units) Table 159. Latin America Actinic Keratosis Drugs Sales Market Share by Country (2021-2026) Table 160. Latin America Actinic Keratosis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Actinic Keratosis Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Actinic Keratosis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Actinic Keratosis Drugs Market Share by Country (2021-2026) Table 165. Latin America Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Actinic Keratosis Drugs Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Actinic Keratosis Drugs Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Actinic Keratosis Drugs Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Actinic Keratosis Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Actinic Keratosis Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Actinic Keratosis Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Actinic Keratosis Drugs Market Share by Country (2021-2026) Table 175. Middle East and Africa Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Actinic Keratosis Drugs Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Actinic Keratosis Drugs Distributors List Table 180. Actinic Keratosis Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Actinic Keratosis Drugs Image Figure 2. Global Actinic Keratosis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Actinic Keratosis Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Actinic Keratosis Drugs Sales (2021-2032) & (K Units) Figure 5. Photodynamic Therapy Drugs Image Figure 6. Global Photodynamic Therapy Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Topical Treatment Drugs Image Figure 8. Global Topical Treatment Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Combination Therapy Drugs Image Figure 10. Global Combination Therapy Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Actinic Keratosis Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Actinic Keratosis Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Actinic Keratosis Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Actinic Keratosis Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Actinic Keratosis Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Actinic Keratosis Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Actinic Keratosis Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Actinic Keratosis Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Actinic Keratosis Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Actinic Keratosis Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Actinic Keratosis Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Actinic Keratosis Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Actinic Keratosis Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Actinic Keratosis Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Actinic Keratosis Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Actinic Keratosis Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Actinic Keratosis Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Actinic Keratosis Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Actinic Keratosis Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Actinic Keratosis Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Actinic Keratosis Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Actinic Keratosis Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Actinic Keratosis Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Actinic Keratosis Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Actinic Keratosis Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Actinic Keratosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Actinic Keratosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Actinic Keratosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Actinic Keratosis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Actinic Keratosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Actinic Keratosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Actinic Keratosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Actinic Keratosis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Actinic Keratosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Actinic Keratosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Actinic Keratosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Actinic Keratosis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Actinic Keratosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Actinic Keratosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Actinic Keratosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Actinic Keratosis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Actinic Keratosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Actinic Keratosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Actinic Keratosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Actinic Keratosis Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Actinic Keratosis Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Actinic Keratosis Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Photodynamic Therapy Drugs
  • Topical Treatment Drugs
  • Combination Therapy Drugs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Novartis
  • Vidac Pharma
  • Valeant
  • TOLMAR Pharmaceuticals
  • Taro Pharmaceutical Industries
  • Promius Pharma
  • Perrigo
  • LEO Pharma
  • GALDERMA
  • Biofrontera
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Actinic Keratosis Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Actinic Keratosis Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Actinic Keratosis Drugs Market by Type
  6. 1.3.1 Photodynamic Therapy Drugs
  7. 1.3.2 Topical Treatment Drugs
  8. 1.3.3 Combination Therapy Drugs
  9. 1.4 Global Actinic Keratosis Drugs Market Size by Type
  10. 1.4.1 Global Actinic Keratosis Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Actinic Keratosis Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Actinic Keratosis Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Actinic Keratosis Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Actinic Keratosis Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Actinic Keratosis Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Actinic Keratosis Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Actinic Keratosis Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Actinic Keratosis Drugs Industry Trends
  2. 2.2 Actinic Keratosis Drugs Industry Drivers
  3. 2.3 Actinic Keratosis Drugs Industry Opportunities and Challenges
  4. 2.4 Actinic Keratosis Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Actinic Keratosis Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Actinic Keratosis Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Actinic Keratosis Drugs Price (2021-2026)
  4. 3.4 Global Actinic Keratosis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Actinic Keratosis Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Actinic Keratosis Drugs Company, Product Type & Application
  7. 3.7 Global Actinic Keratosis Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Actinic Keratosis Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Actinic Keratosis Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Actinic Keratosis Drugs Tier 1, Tier 2, and Tier 3
4 Actinic Keratosis Drugs Regional Status and Outlook
  1. 4.1 Global Actinic Keratosis Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Actinic Keratosis Drugs Historic Market Size by Region
  3. 4.2.1 Global Actinic Keratosis Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Actinic Keratosis Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Actinic Keratosis Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Actinic Keratosis Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Actinic Keratosis Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Actinic Keratosis Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Actinic Keratosis Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Actinic Keratosis Drugs by Application
  1. 5.1 Actinic Keratosis Drugs Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Actinic Keratosis Drugs Market Size by Application
  6. 5.2.1 Global Actinic Keratosis Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Actinic Keratosis Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Actinic Keratosis Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Actinic Keratosis Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Actinic Keratosis Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Actinic Keratosis Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Actinic Keratosis Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Actinic Keratosis Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Actinic Keratosis Drugs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Vidac Pharma
  8. 6.2.1 Vidac Pharma Company Information
  9. 6.2.2 Vidac Pharma Business Overview
  10. 6.2.3 Vidac Pharma Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Vidac Pharma Actinic Keratosis Drugs Product Portfolio
  12. 6.2.5 Vidac Pharma Recent Developments
  13. 6.3 Valeant
  14. 6.3.1 Valeant Company Information
  15. 6.3.2 Valeant Business Overview
  16. 6.3.3 Valeant Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Valeant Actinic Keratosis Drugs Product Portfolio
  18. 6.3.5 Valeant Recent Developments
  19. 6.4 TOLMAR Pharmaceuticals
  20. 6.4.1 TOLMAR Pharmaceuticals Company Information
  21. 6.4.2 TOLMAR Pharmaceuticals Business Overview
  22. 6.4.3 TOLMAR Pharmaceuticals Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 TOLMAR Pharmaceuticals Actinic Keratosis Drugs Product Portfolio
  24. 6.4.5 TOLMAR Pharmaceuticals Recent Developments
  25. 6.5 Taro Pharmaceutical Industries
  26. 6.5.1 Taro Pharmaceutical Industries Company Information
  27. 6.5.2 Taro Pharmaceutical Industries Business Overview
  28. 6.5.3 Taro Pharmaceutical Industries Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taro Pharmaceutical Industries Actinic Keratosis Drugs Product Portfolio
  30. 6.5.5 Taro Pharmaceutical Industries Recent Developments
  31. 6.6 Promius Pharma
  32. 6.6.1 Promius Pharma Company Information
  33. 6.6.2 Promius Pharma Business Overview
  34. 6.6.3 Promius Pharma Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Promius Pharma Actinic Keratosis Drugs Product Portfolio
  36. 6.6.5 Promius Pharma Recent Developments
  37. 6.7 Perrigo
  38. 6.7.1 Perrigo Company Information
  39. 6.7.2 Perrigo Business Overview
  40. 6.7.3 Perrigo Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Perrigo Actinic Keratosis Drugs Product Portfolio
  42. 6.7.5 Perrigo Recent Developments
  43. 6.8 LEO Pharma
  44. 6.8.1 LEO Pharma Company Information
  45. 6.8.2 LEO Pharma Business Overview
  46. 6.8.3 LEO Pharma Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 LEO Pharma Actinic Keratosis Drugs Product Portfolio
  48. 6.8.5 LEO Pharma Recent Developments
  49. 6.9 GALDERMA
  50. 6.9.1 GALDERMA Company Information
  51. 6.9.2 GALDERMA Business Overview
  52. 6.9.3 GALDERMA Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GALDERMA Actinic Keratosis Drugs Product Portfolio
  54. 6.9.5 GALDERMA Recent Developments
  55. 6.10 Biofrontera
  56. 6.10.1 Biofrontera Company Information
  57. 6.10.2 Biofrontera Business Overview
  58. 6.10.3 Biofrontera Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Biofrontera Actinic Keratosis Drugs Product Portfolio
  60. 6.10.5 Biofrontera Recent Developments
  61. 6.11 Almirall
  62. 6.11.1 Almirall Company Information
  63. 6.11.2 Almirall Business Overview
  64. 6.11.3 Almirall Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Almirall Actinic Keratosis Drugs Product Portfolio
  66. 6.11.5 Almirall Recent Developments
7 North America by Country
  1. 7.1 North America Actinic Keratosis Drugs Sales by Country
  2. 7.1.1 North America Actinic Keratosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Actinic Keratosis Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Actinic Keratosis Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Actinic Keratosis Drugs Market Size by Country
  6. 7.2.1 North America Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Actinic Keratosis Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Actinic Keratosis Drugs Sales by Country
  2. 8.1.1 Europe Actinic Keratosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Actinic Keratosis Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Actinic Keratosis Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Actinic Keratosis Drugs Market Size by Country
  6. 8.2.1 Europe Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Actinic Keratosis Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Actinic Keratosis Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Actinic Keratosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Actinic Keratosis Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Actinic Keratosis Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Actinic Keratosis Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Actinic Keratosis Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Actinic Keratosis Drugs Sales by Country
  2. 10.1.1 South America Actinic Keratosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Actinic Keratosis Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Actinic Keratosis Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Actinic Keratosis Drugs Market Size by Country
  6. 10.2.1 South America Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Actinic Keratosis Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Actinic Keratosis Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Actinic Keratosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Actinic Keratosis Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Actinic Keratosis Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Actinic Keratosis Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Actinic Keratosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Actinic Keratosis Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Actinic Keratosis Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Actinic Keratosis Drugs Value Chain Analysis
  2. 12.1.1 Actinic Keratosis Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Actinic Keratosis Drugs Production Mode & Process
  7. 12.2 Actinic Keratosis Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Actinic Keratosis Drugs Distributors
  10. 12.2.3 Actinic Keratosis Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst